Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Martin Dr. Beuck is active.

Publication


Featured researches published by Martin Dr. Beuck.


Angewandte Chemie | 1999

Nonsteroidal Antiinflammatory Drugs: A New Generation of Cyclooxygenase Inhibitors

Martin Dr. Beuck

The multitalented therapeutic agent that is used to relieve a variety of ailments, acetylsalicylic acid (Aspirin® ) is facing new competition. The goal is to use tailor-made inhibitors of cyclooxygenase-2 to selectively reduce pain while minimizing side effects. Do these new drugs represent a new generation of nonsteroidal pain relievers?


Angewandte Chemie | 1999

Nichtsteroidale Antirheumatika: Generationswechsel bei den Cyclooxygenase‐Inhibitoren

Martin Dr. Beuck

Dem therapeutischen Multitalent und Dauerbrenner bei Beschwerden aller Art, der Acetylsalicylsaure (Aspirin®), droht Konkurrenz: Mit masgeschneiderten Inhibitoren fur die Cyclooxygenase-2 will man dem Schmerz noch gezielter und mit weniger Nebenwirkungen zu Leibe rucken. Steht mit den neuen Wirkstoffen auch ein Generationswechsel bei nichtsteroidalen Antirheumatika bevor?


Archive | 1995

Cycloalkano-indole and -azaindole derivatives

Ulrich Dr. Müller; Richard Connell; Siegfried Goldmann; Rudi Grutzmann; Martin Dr. Beuck; Hilmar Bischoff; Dirk Denzer; Anke Domdey-Bette; Stefan Wohlfeil


Archive | 1992

Substituted biphenylpyridinones as angiotensin II antagonists

Matthias Dr. Müller-Gliemann; Martin Dr. Beuck; Stanislav Kazda; Johannes-Peter Stasch; Andreas Dr. Knorr; Stefan Wohlfeil; Walter Dr. Hübsch; Jürgen Dr. Dressel; Peter Fey; Rudolf Dr. Hanko; Thomas Dr. Krämer; Ulrich Dr. Müller; Siegfried Zaiss


Archive | 1997

Hetero-linked phenylglycinolamides

Siegfried Goldmann; Ulrich Dr. Müller; Richard Connell; Hilmar Bischoff; Dirk Denzer; Rudi Grutzmann; Martin Dr. Beuck


Archive | 1992

Heterocyclic substituted phenylacetic-acid derivatives, process for their preparation and their pharmaceutical application

Ulrich Dr. Müller; Klaus Mohrs; Jürgen Dr. Dressel; Rudolf Dr. Hanko; Walter Dr. Hübsch; Michael Matzke; Ulrich Niewohner; Siegfried Raddatz; Thomas Dr. Krämer; Matthias Dr. Müller-Gliemann; Hans-Peter Dr. Bellemann; Martin Dr. Beuck; Stanislav Kazda; Stefan Wohlfeil


Archive | 1993

Sulphonylbenzyl-substituted pyridones which are angiotension II receptor antagonists

Rudolf Dr. Hanko; Walter Dr. Hübsch; Jürgen Dr. Dressel; Peter Fey; Thomas Dr. Krämer; Ulrich Dr. Müller; Matthias Dr. Müller-Gliemann; Martin Dr. Beuck; Stanislav Kazda; Claudia Hirth-Dietrich; Andreas Knorr; Johannes-Peter Stasch; Stefan Wohlfeil; Özkan Dr. Yalkinoglu


Archive | 1994

Substituted mono- and bipyridylmethylpyridones

Peter Fey; Walter Dr. Hübsch; Jürgen Dr. Dressel; Rudolf Dr. Hanko; Thomas Dr. Krämer; Ulrich Dr. Müller; Matthias Dr. Müller-Gliemann; Martin Dr. Beuck; Hilmar Bischoff; Stefan Wohlfeil; Dirk Denzer; Stanislav Kazda; Johannes-Peter Stasch; Andreas Knorr; Siegfried Zaiss


Archive | 1994

Heterocyclically substituted phenyl-cyclohexane-carboxylic acid derivatives

Ulrich E. Muller; Jürgen Dr. Dressel; Peter Fey; Rudolf H. Hanko; Walter Dr. Hübsch; Thomas Dr. Krämer; Matthias Dr. Müller-Gliemann; Martin Dr. Beuck; Stanislav Kazda; Stefan Wohlfeil; Andreas Knorr; Johannes-Peter Stasch; Siegfried Zaiss


Archive | 1994

Heterocyclically substituted phenylacetic acid derivatives and their use in medicaments

Ulrich Dr. Müller; Klaus Mohrs; Jürgen Dr. Dressel; Rudolf Dr. Hanko; Walter Dr. Hübsch; Michael Matzke; Ulrich Niewohner; Siegfried Raddatz; Thomas Dr. Krämer; Matthias Dr. Müller-Gliemann; Hans-Peter Belleman; Martin Dr. Beuck; Stanislav Kazda; Stefan Wohlfeil

Researchain Logo
Decentralizing Knowledge